Epiphyseal Separation for Height Increase in Girls: Not Recommended
Intentional epiphyseal separation (growth plate disruption) should never be performed to increase height in girls, as this procedure causes growth arrest rather than growth enhancement and carries significant risks of limb deformity, limb length discrepancy, and permanent disability.
Why This Procedure is Contraindicated
Fundamental Misunderstanding of Growth Plate Biology
The question reflects a dangerous misconception about how growth plates function. Epiphyseal separation—whether traumatic or intentional—disrupts rather than enhances growth:
Growth plates enable longitudinal bone growth through organized chondrocyte proliferation and ossification. Disrupting this architecture halts growth rather than stimulating it 1, 2.
Physeal injuries lead to growth disturbances in up to 10% of cases, including premature physeal closure, bony bar formation, angular deformities, and limb length discrepancies 2.
The complications from growth plate injury include fibrogenesis, pathological osteogenesis, and formation of bone bridges that permanently arrest growth 1.
Clinical Evidence of Harm
The medical literature consistently demonstrates that epiphyseal disruption causes growth problems:
Epiphysiodesis (intentional growth plate closure) is used therapeutically to STOP growth, not enhance it—specifically to correct leg length discrepancies by halting growth in the longer limb 3.
Even in therapeutic contexts where growth plates are manipulated (e.g., ACL reconstruction using epiphyseal techniques), significant complications occur including overgrowth (paradoxically), limb length inequality, and angular deformities 4.
Studies of physeal fractures show that periosteal entrapment and growth plate disruption lead to premature physeal closure and deformity 5.
Evidence-Based Approaches to Height Enhancement
If the goal is to increase final adult height in a girl with short stature, the following evidence-based interventions should be considered instead:
1. Recombinant Human Growth Hormone (rhGH)
For girls with documented growth disorders:
rhGH therapy is indicated for persistent growth failure (height below 3rd percentile, height velocity below 25th percentile) in conditions like chronic kidney disease, Turner syndrome, or growth hormone deficiency 6.
Treatment must begin before epiphyseal closure (grade X, strong recommendation) 6.
Prepubertal children respond better than pubertal patients to rhGH therapy 7.
2. Delaying Skeletal Maturation (in specific contexts)
For girls with short stature and early/precocious puberty:
GnRH analogues combined with rhGH can delay epiphyseal closure and increase treatment duration, potentially improving final adult height in girls with idiopathic short stature and relatively early puberty 8.
This approach works by reducing estrogen exposure, which normally accelerates epiphyseal closure, thereby extending the growth period 8.
Skeletal maturity typically occurs around age 14 in girls 7.
3. Addressing Underlying Causes
Before any intervention:
Evaluate for treatable causes of short stature: nutritional deficiencies, endocrinopathies (hypothyroidism, growth hormone deficiency), chronic diseases, genetic conditions (Turner syndrome, SHOX gene mutations) 9.
Assess growth velocity over 4-6 months, not just absolute height 9.
Determine bone age via left wrist radiography to assess remaining growth potential 6.
Calculate target height based on parental heights to distinguish pathologic from familial short stature 9.
Critical Safety Considerations
Absolute Contraindications to Growth Plate Manipulation
Any intervention affecting growth plates is contraindicated when:
- Epiphyses are closed (grade X, strong recommendation) 6
- Active malignancy is present (grade X, strong recommendation) 6
- Patient/family unwillingness exists (grade X, strong recommendation) 6
Realistic Expectations
Even with appropriate medical therapy:
Height gains are modest: rhGH therapy in appropriate candidates typically increases height SDS by 0.9-1.9 over several years 6, 10.
Not all children with idiopathic short stature benefit significantly from intervention 10.
Constitutional short stature and familial short stature often represent normal variants that do not require or respond to treatment 9.
Common Pitfalls to Avoid
Never attempt to "stimulate" growth by damaging growth plates—this causes growth arrest, not enhancement.
Do not confuse guided growth techniques (which correct deformities by modulating growth differentially across a growth plate) with procedures to increase overall height 3.
Recognize that surgical interventions on growth plates (epiphysiodesis, osteotomies) are corrective procedures for deformities or leg length discrepancies, not height enhancement strategies 7, 3.
Understand that overgrowth following growth plate injury is a pathological complication, not a therapeutic goal 4.